Abstract
It is clear that regenerative medicine therapies will dominate the future landscape, particularly for genetic disorders and other diseases that have been proven intractable with current therapies. As we explore unique combinations of rapidly emerging fields—from computational biology to genome editing to molecular therapeutics—the past goal of ameliorating symptoms of disease is rapidly giving way to the goal of restoring a patient to health and normal function.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 763-766 |
| Number of pages | 4 |
| Journal | Clinical pharmacology and therapeutics |
| Volume | 103 |
| Issue number | 5 |
| DOIs | |
| State | Published - May 2018 |
Bibliographical note
Funding Information:National Institutes of Health: NIH R01 AR063070, NIH R01 AR059947, NIH/NCI P01 CA065493, NIH P01 CA111412.
Publisher Copyright:
© 2018 American Society for Clinical Pharmacology and Therapeutics